nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstract
|
|
|
2001 |
31 |
2-3 |
p. 353- 1 p. |
artikel |
2 |
A case-control study of lung cancer among Czech women
|
Kubı́k, Antonı́n |
|
2001 |
31 |
2-3 |
p. 111-122 12 p. |
artikel |
3 |
Activity and toxicity of gemcitabine and gemcitabine+vinorelbine in advanced non-small-cell lung cancer elderly patients
|
Gridelli, Cesare |
|
2001 |
31 |
2-3 |
p. 277-284 8 p. |
artikel |
4 |
Adenovirus expressing p27Kip1 induces growth arrest of lung cancer cell lines and suppresses the growth of established lung cancer xenografts
|
Park, Kyung-Ho |
|
2001 |
31 |
2-3 |
p. 149-155 7 p. |
artikel |
5 |
Alteration of cell growth and morphology by overexpression of transforming growth factor β type II receptor in human lung adenocarcinoma cells
|
Kim, Tae-Kyun |
|
2001 |
31 |
2-3 |
p. 181-191 11 p. |
artikel |
6 |
A phase II trial of oral UFT plus cisplatin (CDDP) in patients with non-small cell lung cancer (NSCLC)
|
Saito, Junichi |
|
2001 |
31 |
2-3 |
p. 285-293 9 p. |
artikel |
7 |
Benign solitary fibrous tumor of the parietal pleura which invaded the intercostal muscle
|
Nonaka, Makoto |
|
2001 |
31 |
2-3 |
p. 325-329 5 p. |
artikel |
8 |
Bronchorrhea revealing cervix adenocarcinoma metastastic to the lung
|
Epaulard, Olivier |
|
2001 |
31 |
2-3 |
p. 331-334 4 p. |
artikel |
9 |
Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine
|
De Pas, Tommaso |
|
2001 |
31 |
2-3 |
p. 267-270 4 p. |
artikel |
10 |
Comment on Katsimbri et al.: endobronchial metastases secondary to solid tumours, Lung Cancer
|
Debeljak, A. |
|
2001 |
31 |
2-3 |
p. 351-352 2 p. |
artikel |
11 |
Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients
|
Pujol, Jean-Louis |
|
2001 |
31 |
2-3 |
p. 221-231 11 p. |
artikel |
12 |
Decreased myelotoxicity of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) with cisplatin infusion on day 15
|
Cortesi, E. |
|
2001 |
31 |
2-3 |
p. 271-276 6 p. |
artikel |
13 |
Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis
|
Khuder, Sadik A. |
|
2001 |
31 |
2-3 |
p. 139-148 10 p. |
artikel |
14 |
Expression of syndecan-1 is common in human lung cancers independent of expression of epidermal growth factor receptor
|
Toyoshima, Eri |
|
2001 |
31 |
2-3 |
p. 193-202 10 p. |
artikel |
15 |
Fatal infection in patients treated for small cell lung cancer in the Institute of Tuberculosis and Chest Diseases in the years 1980–1994
|
Remiszewski, P. |
|
2001 |
31 |
2-3 |
p. 101-110 10 p. |
artikel |
16 |
Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B
|
Kindler, Hedy L. |
|
2001 |
31 |
2-3 |
p. 311-317 7 p. |
artikel |
17 |
Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer
|
Biroš, Erik |
|
2001 |
31 |
2-3 |
p. 157-162 6 p. |
artikel |
18 |
Increased serum levels of basic fibroblast growth factor in lung cancer patients: relevance to response of therapy and prognosis
|
Ueno, Kiyonobu |
|
2001 |
31 |
2-3 |
p. 213-219 7 p. |
artikel |
19 |
Intramedullary spinal cord metastases (ISCM) and non-small cell lung carcinoma (NSCLC): clinical patterns, diagnosis and therapeutic considerations
|
Potti, Anil |
|
2001 |
31 |
2-3 |
p. 319-323 5 p. |
artikel |
20 |
Loss of p16 and/or pRb protein expression in NSCLC
|
Chen, Jung-Ta |
|
2001 |
31 |
2-3 |
p. 163-170 8 p. |
artikel |
21 |
Lung cancer mortality rates in birth cohorts in the United States from 1960 to 1994
|
Mannino, David M. |
|
2001 |
31 |
2-3 |
p. 91-99 9 p. |
artikel |
22 |
Male lung cancer patients die earlier in life Austria 1976–1996
|
Groman, Ernest |
|
2001 |
31 |
2-3 |
p. 335-337 3 p. |
artikel |
23 |
Molecular Biomarkers Workshop: a European Strategy for Developing Lung Cancer Molecular Diagnostics in High Risk Populations
|
Field, J.K. |
|
2001 |
31 |
2-3 |
p. 339-345 7 p. |
artikel |
24 |
Ninth International Conference on Lung Cancer
|
|
|
2001 |
31 |
2-3 |
p. 355-359 5 p. |
artikel |
25 |
Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion
|
Castagneto, Bruno |
|
2001 |
31 |
2-3 |
p. 303-310 8 p. |
artikel |
26 |
Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer
|
Ratanatharathorn, Vorachai |
|
2001 |
31 |
2-3 |
p. 257-265 9 p. |
artikel |
27 |
Phase I study of paclitaxel (Taxol®) plus vinorelbine (Navelbine®) in patients with untreated stage IIIb and IV non-small cell lung cancer
|
Breton, J.L. |
|
2001 |
31 |
2-3 |
p. 295-301 7 p. |
artikel |
28 |
Primary lung sarcomas: long survivors obtained with iterative complete surgery
|
Magné, Nicolas |
|
2001 |
31 |
2-3 |
p. 241-245 5 p. |
artikel |
29 |
Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells
|
Casibang, Marchessini |
|
2001 |
31 |
2-3 |
p. 203-212 10 p. |
artikel |
30 |
Quality of life in lung cancer patients
|
Montazeri, Ali |
|
2001 |
31 |
2-3 |
p. 233-240 8 p. |
artikel |
31 |
Reversible hepatic coma possibly induced by docetaxel treatment
|
Chen, Yuh-Min |
|
2001 |
31 |
2-3 |
p. 347-348 2 p. |
artikel |
32 |
The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients: a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT)
|
Freyer, Gilles |
|
2001 |
31 |
2-3 |
p. 247-256 10 p. |
artikel |
33 |
Time for a global strategy to improve the treatment of lung cancer?
|
Stephens, Richard |
|
2001 |
31 |
2-3 |
p. 349- 1 p. |
artikel |
34 |
Tissue factor is the only activator of coagulation in cultured human lung cancer cells
|
Keller, Thorsten |
|
2001 |
31 |
2-3 |
p. 171-179 9 p. |
artikel |
35 |
Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe
|
Janssen-Heijnen, Maryska L.G. |
|
2001 |
31 |
2-3 |
p. 123-137 15 p. |
artikel |